Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

40 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, not recruiting

Real World Registry for Use of the Ion Endoluminal System

NCT06004440

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Orlando Health Orlando Regional Medical Center Orlando, Florida, United States
  • Ascension Alexian Brothers Elk Grove Village, Illinois, United States
  • Blessing Hospital Quincy, Illinois, United States
  • Kansas University Medical Center Kansas City, Kansas, United States
View all 16 locations
View Trial Details
Active, not recruiting

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

NCT03157128

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 85 locations
View Trial Details
Active, not recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

NCT04776447

Conditions
Bronchial Neoplasms, Carcinoma Bronchiogenic Stage III, Carcinoma, Bronchogenic, +10 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

NCT05054725

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • BRCR Medical Center Inc. Plantation, Florida, United States
  • Cancer Specialists of North Florida Saint Augustine, Florida, United States
  • GenHarp Clinical Solutions Evergreen Park, Illinois, United States
View all 60 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions